ROSSI, LUIGIA
 Distribuzione geografica
Continente #
NA - Nord America 13.665
EU - Europa 8.161
AS - Asia 5.068
SA - Sud America 352
AF - Africa 56
OC - Oceania 35
Continente sconosciuto - Info sul continente non disponibili 17
Totale 27.354
Nazione #
US - Stati Uniti d'America 13.539
GB - Regno Unito 3.124
CN - Cina 2.751
UA - Ucraina 1.265
SG - Singapore 1.242
IT - Italia 974
SE - Svezia 740
DE - Germania 506
FI - Finlandia 494
TR - Turchia 466
RU - Federazione Russa 422
BR - Brasile 291
IE - Irlanda 281
JP - Giappone 147
VN - Vietnam 113
FR - Francia 108
IN - India 87
CA - Canada 86
KR - Corea 60
PL - Polonia 46
ES - Italia 37
BE - Belgio 33
MX - Messico 33
AU - Australia 32
PK - Pakistan 32
HK - Hong Kong 30
NL - Olanda 27
BD - Bangladesh 23
ZA - Sudafrica 23
AR - Argentina 19
IR - Iran 18
AT - Austria 16
RO - Romania 16
EU - Europa 14
LT - Lituania 13
ID - Indonesia 12
TG - Togo 12
AE - Emirati Arabi Uniti 11
EC - Ecuador 11
MA - Marocco 11
CO - Colombia 10
SA - Arabia Saudita 10
IL - Israele 9
PT - Portogallo 9
IQ - Iraq 8
KZ - Kazakistan 8
VE - Venezuela 8
CH - Svizzera 7
CL - Cile 6
AZ - Azerbaigian 5
CZ - Repubblica Ceca 5
LV - Lettonia 5
NO - Norvegia 5
PH - Filippine 5
AM - Armenia 4
PA - Panama 4
UZ - Uzbekistan 4
A2 - ???statistics.table.value.countryCode.A2??? 3
DK - Danimarca 3
EE - Estonia 3
JO - Giordania 3
KH - Cambogia 3
LK - Sri Lanka 3
NG - Nigeria 3
NZ - Nuova Zelanda 3
PE - Perù 3
TH - Thailandia 3
TW - Taiwan 3
BG - Bulgaria 2
BY - Bielorussia 2
ET - Etiopia 2
GE - Georgia 2
GR - Grecia 2
HR - Croazia 2
IS - Islanda 2
LA - Repubblica Popolare Democratica del Laos 2
NP - Nepal 2
RS - Serbia 2
SI - Slovenia 2
SM - San Marino 2
TN - Tunisia 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
BO - Bolivia 1
CR - Costa Rica 1
CY - Cipro 1
EG - Egitto 1
GA - Gabon 1
HN - Honduras 1
HU - Ungheria 1
JM - Giamaica 1
KE - Kenya 1
LU - Lussemburgo 1
MD - Moldavia 1
MK - Macedonia 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
UY - Uruguay 1
Totale 27.354
Città #
Southend 2.825
Fairfield 1.692
Woodbridge 1.548
Ashburn 1.165
Houston 1.091
Jacksonville 1.010
Ann Arbor 892
Chandler 737
Cambridge 653
Seattle 647
Wilmington 580
Nanjing 541
Singapore 534
Dallas 410
Beijing 371
Izmir 348
Dublin 279
Boardman 267
Urbino 243
Nanchang 229
Helsinki 196
New York 178
San Mateo 167
Los Angeles 163
Princeton 149
Shenyang 125
Hebei 120
Jiaxing 102
Düsseldorf 99
Munich 97
Tianjin 97
Changsha 84
Buffalo 69
Istanbul 69
Kunming 62
San Diego 61
Mülheim 57
Bremen 55
San Francisco 52
Jinan 51
Moscow 51
Seongnam 50
Santa Clara 48
Council Bluffs 46
Shanghai 46
Guangzhou 45
Ho Chi Minh City 45
London 44
Hangzhou 42
São Paulo 42
Zhengzhou 42
Tokyo 38
Toronto 37
Brussels 32
Frankfurt am Main 31
Velikiy Novgorod 31
Warsaw 30
Turku 29
Brooklyn 27
Ningbo 27
Rome 27
Montreal 26
Poplar 26
Stockholm 24
Changchun 23
Ancona 22
Chicago 22
Denver 22
Atlanta 21
Des Moines 21
Hong Kong 21
Taizhou 21
Bologna 20
Hanoi 20
Auburn Hills 17
Johannesburg 17
Fano 16
Portsmouth 16
Redwood City 16
Chennai 15
Orem 15
Rawalpindi 15
Lauterbourg 14
Leawood 14
Amsterdam 13
Augusta 13
Mexico City 13
Shenzhen 13
Alexandria 12
Kraków 12
Lanzhou 12
Lomé 12
Norwalk 12
Nuremberg 12
Paris 12
Phoenix 12
Ankara 11
Canberra 11
Melbourne 11
Querétaro 11
Totale 19.561
Nome #
Reengineering red blood cells for cellular therapeutics and diagnostics 363
A new therapy prevents intellectual disability in mouse with phenylketonuria 299
Ex vivo encapsulation of dexamethasone sodium phosphate into human autologous erythrocytes using fully automated biomedical equipment 285
Engineering erythrocytes for the modulation of drugs' and contrasting agents' pharmacokinetics and biodistribution 271
2',3'-Dideoxycytidine metabolism in a new drug-resistant cell line 260
Dexamethasone improves redox state in ataxia telangiectasia cells by promoting an NRF2-mediated antioxidant response 259
Cytotoxic activity of 2-Fluoro-ara-AMP and 2-Fluoro-ara-AMP-loaded erythrocytes against human breast carcinoma cell lines. 256
A NONLINEAR THREE-COMPARTMENT MODEL FOR THE ADMINISTRATION OF 2’, 3’- DIDEOXYCYTIDINE BY USING RED BLOOD CELLS AS BIOREACTORS 255
2',3'-Dideoxycytidine induced drug resistance in human cells 254
Pharmacokinetic and antiretroviral activity in mice of oral [P(1),P(2)-bis[2-(adenin-9-yl)ethoxymethyl]phosphonate], a prodrug of 9-(2-phosphonylmethoxyethyl)adenine 251
Effect of macrophage depletion on viral DNA rebound following antiretroviral therapy in a murine model of AIDS (MAIDS) 247
In vivo effects of dexamethasone on blood gene expression in ataxia telangiectasia 247
Macrophage Depletion by Free Bisphosphonates and Zoledronate-Loaded Red Blood Cells 240
Improved cellular uptake of functionalized single-walled carbon nanotubes 239
A new acyclic heterodinucleotide active against human immunodeficiency virus and herpes simplex virus 238
Immunophilin-loaded erythrocytes as a new delivery strategy for immunosuppressive drugs 237
Erythrocyte-based drug delivery 236
ATM splicing variants as biomarkers for low dose dexamethasone treatment of A-T 234
Drug delivery through phagocytosis of red blood cells 233
Label-free quantification of Tacrolimus in biological samples by atomic force microscopy 233
Red Blood Cell-Based Delivery of Drugs and Nanomaterials for Therapeutic and Diagnostic Applications 232
Inhibition of HIV-1 replication in macrophages by red blood cell-mediated delivery of a heterodinucleotide of lamivudine and tenofovir 230
Acetaldehyde, ethanol and acetone concentrations in blood of alcohol-treated mice receiving aldehyde dehydrogenase-loaded erythrocytes 228
Erythrocytes as a controlled drug delivery system: clinical evidences 226
Inhibition of HIV-1 replication in macrophages by a heterodinucleotide of lamivudine and tenofovir 226
Drug delivery by red blood cells 226
Ultrastructural analysis of pancreatic acinar cells from mice fed on genetically modified soybean 225
Activation of NRF2 by dexamethasone in ataxia telangiectasia cells involves KEAP1 inhibition but not the inhibition of p38 224
Drug delivery systems 223
Inhibition of murine AIDS by combination of AZT and dideoxycytidine 5'-triphosphate 222
Erythrocyte-mediated delivery of phenylalanine ammonia lyase for the treatment of phenylketonuria in BTBR-Pahenu2 mice 220
Inhibition of murine AIDS by a heterodinucleotide of azidothymidine and 9-(R)-2-(phosphonomethoxypropyl)adenine 219
2',3'- Dideoxycytidine permeation of the human erythrocyte membrane. 219
Human red blood cells as bioreactors for the release of 2', 3'-dideoxycytidine, an inhibitor of HIV infectivity. 219
Approaches to erythrocyte-mediated drug delivery 218
Adherence and intracellular survival within human macrophages of Enterococcus faecalis isolates from coastal marine sediment 218
Targeting antiviral nucleotide analogues to macrophages 217
"Transformed erythrocytes, process for preparing the same, and their use in pharmaceutical compositions" 214
Red blood cells as advanced drug delivery systems for antiviral nucleoside analogues 211
Acetaldehyde dehydrogenase-loaded erythrocytes as bioreactors for the removal of blood acetaldehyde 210
Acyclovir prodrug and its use in pharmaceutical compositions 209
Prolonged islet allograft survival in diabetic mice upon macrophage depletion by clodronate-loaded erythrocytes 204
Inhibition of murine AIDS by reduced glutathione. 204
Acetaldehyde oxidation by aldehyde dehydrogenase-loaded erythrocytes. 203
Effect of listeriolysin O-loaded erythrocytes on Mycobacterium avium replication within macrophages 198
Observation of erythrocyte dynamics in the retinal capillaries and choriocapillaris using ICG-loaded erythrocyte ghost cells 194
An ex-vivo erythrocyte model for investigating oxidative metabolism 194
Use of nonvolatile buffers in liquid chromatography/mass spectrometry: advantages of capillary-scale particle beam interfacing 192
Targeting nucleotide dimers containing antiviral nucleosides 192
Red Blood Cell Membrane Processing for Biomedical Applications 192
Erythrocyte-mediated delivery of recombinant enzymes 189
Macrophage protection by nucleoside and nucleotide analogue administration 185
Erythrocyte-mediated delivery of dexamethasone in patients with mild-to-moderate ulcerative colitis, refractory to mesalamine: a randomized, controlled study 185
Role and mechanism of hexokinase decay during reticulocyte maturation and cell aging 184
Human red blood cells as bioreactors for the release of 2',3'-dideoxycytidine, an inhibitor of HIV infectivity. 183
Membrane-bound immunoglobulins increase during red blood cell aging. 182
Fine distribution of CLOCK protein in hepatocytes of hibernating dormice. 182
Redox homeostasis as a target for new antimycobacterial agents 182
REVERSED-PHASE LIQUID CHROMATOGRAPHIC DETERMINATION OF 2’, 3’-DIDEOXYCYTIDINE IN HUMAN BLOOD SAMPLES 181
Preclinical evaluation of an innovative anti-TAM approach based on zoledronate-loaded erythrocytes 181
Human red blood cells as bioreactors for the release of 2',3'-dideoxycytidine, an inhibitor of HIV infectivity 180
Normalization of hyperglycemia in diabetic mice by enzyme-loaded erythrocytes 180
In vivo accelerated acetaldehyde metabolism using acetaldehyde dehydrogenase-loaded erythrocytes 179
Erythrocyte-mediated delivery of a new homodinucleotide active against human immunodeficiency virus and herpes simplex virus 178
In vivo accelerated acetaldehyde metabolism using acetaldehyde dehydrogenase-loaded erythrocytes. 176
Erythrocyte-mediated delivery of drugs, peptides and modified oligonucleotides 176
Inhibition of murine AIDS by combination of AZT and DDCTP-loaded erythrocytes 176
ALCUNE PROPRIETÀ DI GLOBULI ROSSI UMANI SOTTOPOSTI A DIALISI IPOTONICA E RISIGILLAMENTO DA UTILIZZARE COME VEICOLI O BIOREATTORI. 175
Red blood cell phagocytosis following hexokinase inactivation. 175
A new homodimer of acyclovir as a prodrug with increased solubility and antiviral activity 175
Efficient Cocaine Degradation by Cocaine Esterase-Loaded Red Blood Cells 173
Acetaldehyde, ethanol and acetone concetrations in blood of alcohol-treated mice receiving aldehyde dehydrogenase-loaded erythrocytes. 171
Efficacy and toxicity of long-term administration of 2',3'-dideoxycytidine in the LP-BM5 murine-induced immunodeficiency model 170
FIV infection of macrophages: in vitro and in vivo inhibition by dideoxycytidine-5'-triphosphate. 169
Effect of age on some properties of mice erythrocytes 169
Effect of phenylhydrazine on red blood cell metabolism. 168
Modulated red blood cell survival by membrane protein clustering 168
Inhibition of HIV-1 and LP-BM5 replication in macrophages by dideoxycytidine and dideoxycytidine 5'-triphosphate 166
Metabolism, mitochondrial uptake and toxicity of 2’,3’-dideoxycytidine 166
Ongoing Developments and Clinical Progress in Drug-Loaded Red Blood Cell Technologies 166
Transformed erythrocytes, process for preparing the same, and their use in pharmaceutical compositions” PCT/EP 92/01291 165
Synthesis and biological application of a new heterodinucleotide with both anti-HSV and anti-HIV activity 164
Inhibition of murine retrovirus induced immunodeficiency by nucleoside analogues and combination therapy. 164
null 164
Macrophage protection against human immunodeficiency virus or herpes simplex virus by red blood cell-mediated delivery of a heterodinucleotide of azidothymidine and acyclovir 163
Preparation of glutathione derivatives as antiviral agents 163
Improved metabolic properties of hexokinase-overloaded human erythrocytes 162
Erythrocytes-mediated delivery of Dexamethasone in steroid-dependent IBD patients – A pilot uncontrolled study 161
Azidothymidine homodinucleotide-loaded erythrocytes and bioreactors for slow delivery of the antiretroviral drug azidothymidine 159
In vitro and in vivo methanol degradation by alcohol oxidase-loaded erythrocytes 159
Macrophage uptake of SWNT-COOC18H37 derivatives coated by phosphatidylethanolamine or phosphatidylserine 158
Synthesis, caracterization and erythrocyte encapsulation of an azidothymidine homodinucleotide 158
Macrophage protection by nucleoside and nucleotide analogue administration 158
Heterodimer-loaded erythrocytes as bioreactors for slow delivery of the antiviral drug azidothymidine and the antimycobacterial drug ethambutol 157
Phagocytosis reduces HIV-1 production in human monocytes/macrophages infected in vitro. 155
Preclinical developments of enzyme-loaded red blood cells 155
Erythrocytes as carriers of reduced glutathione (GSH) in the treatment of retroviral infections 155
Targeting antiviral nucleotide analogues to macrophages 154
Red Blood Cell Loading: a Selection of Procedures 153
Role of hexokinase in the regulation of erythrocyte hexose monophosphate pathway under oxidative stress 153
Totale 20.016
Categoria #
all - tutte 96.917
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 96.917


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.776 0 0 0 0 0 230 184 226 355 242 389 150
2021/20221.665 140 130 171 219 69 59 66 95 124 119 32 441
2022/20232.447 300 107 40 242 246 527 7 174 433 121 160 90
2023/2024697 77 72 47 89 56 143 21 26 8 87 7 64
2024/20252.731 137 132 593 184 81 188 278 154 284 197 255 248
2025/20263.572 586 598 678 1.053 635 22 0 0 0 0 0 0
Totale 27.663